Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How model-free adaptive control improves grasp stability of underactuated robotic hands on deformable objects — synthesising 60+ patents and research publications.
Article | Report SPAD technology landscape 2026: CMOS integration, NIR enhancement, III-V materials, and patent trends across LiDAR, quantum comms, and medical imaging.
Article | Report IL-1, IL-6, and prophylactic approaches reshaping the CRS prevention pipeline in CAR-T therapy. Explore patent filings, clinical signals, and emerging strategies.
Article | Report Liquid metal cooling patent landscape 2026: gallium alloys, alkali metals, and the race to replace water cooling in AI chips, EVs, and CSP receivers.
Article | Report A technical deep-dive into PLA, PHA, and PBS bio-based polymers: synthesis pathways, mechanical performance, application domains, and 2026 innovation trends from 60+ peer-reviewed sources.
Article | Report Beyond teduglutide: how glepaglutide, apraglutide, GLP-2 peptibodies and dual GLP-1/GLP-2 agonists are reshaping the SBS drug pipeline. Patent and clinical signals analysed.
Article | Report How bilateral teleoperation with haptic feedback reduces task completion time in remote surgical robotics — evidence from 50+ patents and studies.
Article | Report Layered oxides, Prussian blue analogs, and NASICON phosphates compared across energy density, cycle life, cost, and air stability for SIB commercialization.
Article | Report Capsule FMT achieves 80% efficacy in rCDI. Explore the drug pipeline: lyophilized cFMT, defined microbial consortia, engraftment biology, and regulatory signals.
Article | Report Explore the 2026 sodium sulfur battery technology landscape: RT-NaS breakthroughs, solid-state electrolytes, key patents, and strategic implications for grid storage.
Article | Report How soft tissue artifact corrupts exoskeleton torque estimation during gait—and 7 proven engineering strategies to reduce error, from ESO to iterative learning control.
Article | Report A 2026 landscape of refractory high-entropy alloys (RHEAs) for aerospace and nuclear applications — covering mechanical performance, oxidation resistance, radiation tolerance, and additive manufacturing advances.
Article | Report Motilin receptor agonists, ghrelin mimetics, 5-HT4 agonists, and GLP-1 modulation: a patent and literature analysis of the gastroparesis drug pipeline.
Article | Report How multibody dynamics simulation of flexible robot links improves trajectory tracking accuracy in high-speed pick-and-place systems. Expert analysis of models, tools & patents.
Article | Report SDH mutation targeting, VEGFR inhibition, and radioligand therapy in the PPGL drug pipeline. Clinical evidence, emerging targets, and strategic implications.